Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-11 Purchase |
2025-03-11 6:42 pm |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
343,631 | $2.16 | $742,243 | 56,143,640 (Direct) |
View |
| 2025-03-10 Purchase |
2025-03-10 5:11 pm |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
25,000 | $2.3 | $57,500 | 176,000 (Indirect Direct) |
View |
| 2025-03-06 Purchase |
2025-03-07 3:32 pm |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
60,000 | $2.3428 | $140,568 | 151,000 (Indirect Direct) |
View |
| 2024-08-29 Purchase |
2024-08-29 4:35 pm |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
283,516 | $2.61 | $739,977 | 56,086,009 (Direct) |
View |
| 2023-11-06 Purchase |
2023-11-08 3:29 pm |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
30,000 | $4.58 | $137,400 | 91,000 (Indirect Direct) |
View |
| 2023-09-22 Purchase |
2023-09-26 12:26 pm |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
20,000 | $4.91 | $98,200 | 1,441,642 (Indirect) |
View |
| 2023-09-12 Purchase |
2023-09-14 4:38 pm |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
20,000 | $5.19 | $103,800 | 9,530,340 (Indirect Direct) |
View |
| 2023-08-08 Purchase |
2023-08-09 12:22 pm |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
30,000 | $5.9 | $177,000 | 1,421,642 (Indirect) |
View |
| 2023-05-26 Purchase |
2023-05-26 2:53 pm |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
14,500 | $6.85 | $99,325 | 283,959 (Indirect Direct) |
View |
| 2023-05-26 Purchase |
2023-05-26 2:50 pm |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
153,000 | $6.5211 | $997,728 | 56,012,493 (Direct) |
View |
| 2022-12-16 Purchase |
2022-12-20 10:18 am |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
85,102 | $10.1 | $859,249 | 55,859,493 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-01 Option Award |
2025-01-03 3:44 pm |
N/A 2035-01-01 |
AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer |
832,033 | $0 | 4,106,747 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 3:40 pm |
N/A 2035-01-01 |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
832,033 | $0 | 4,661,804 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 3:37 pm |
N/A 2035-01-01 |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
1,352,054 | $0 | 7,942,951 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 3:36 pm |
N/A 2035-01-01 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
2,730,109 | $0 | 10,990,332 (Direct) |
View |
| 2024-12-04 Gift |
2024-12-05 4:47 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
286,000 | $0 | 55,800,009 (Direct) |
View |
| 2024-11-25 Exercise |
2024-11-26 5:38 pm |
N/A 2030-11-27 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 65,244,232 (Direct) |
View |
| 2024-11-25 Exercise |
2024-11-26 5:38 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 65,244,232 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 4:09 pm |
N/A 2030-11-27 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 65,244,232 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 4:09 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 65,244,232 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-24 6:38 pm |
N/A 2027-03-23 |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
83,334 | $0 | 13,443,445 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-24 6:38 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
83,334 | $0.188 | 13,443,445 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-24 6:30 pm |
2025-06-12 2034-06-21 |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
163,934 | $0 | 660,979 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-24 6:19 pm |
2025-06-12 2034-06-21 |
AbCellera Biologics Inc. | ABCL | Lo Andrew Director |
163,934 | $0 | 302,490 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-24 6:15 pm |
2025-06-12 2034-06-21 |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
163,934 | $0 | 790,979 (Direct) |
View |
| 2024-05-31 Exercise |
2024-06-03 4:21 pm |
N/A 2030-11-27 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 64,960,716 (Direct) |
View |
| 2024-05-31 Exercise |
2024-06-03 4:21 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 64,960,716 (Direct) |
View |
| 2024-02-26 Exercise |
2024-02-27 2:12 pm |
N/A 2030-11-27 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 64,960,716 (Direct) |
View |
| 2024-02-26 Exercise |
2024-02-27 2:12 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 64,960,716 (Direct) |
View |
| 2024-01-14 Option Award |
2024-01-16 6:23 pm |
N/A 2034-01-14 |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
770,416 | $0 | 3,913,105 (Direct) |
View |
| 2024-01-14 Option Award |
2024-01-16 6:21 pm |
N/A 2034-01-14 |
AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer |
616,333 | $0 | 3,274,714 (Direct) |
View |
| 2024-01-14 Option Award |
2024-01-16 6:18 pm |
N/A 2034-01-14 |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
770,416 | $0 | 6,590,897 (Direct) |
View |
| 2024-01-14 Option Award |
2024-01-16 6:14 pm |
N/A 2034-01-14 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
2,095,532 | $0 | 8,484,723 (Direct) |
View |
| 2023-12-19 Gift |
2023-12-19 6:08 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
210,000 | $0 | 55,802,493 (Direct) |
View |
| 2023-11-23 Exercise |
2023-11-27 4:45 pm |
N/A 2030-11-27 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 63,075,184 (Direct) |
View |
| 2023-11-23 Exercise |
2023-11-27 4:45 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 63,075,184 (Direct) |
View |
| 2023-08-24 Exercise |
2023-08-25 1:57 pm |
N/A 2030-11-27 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 63,075,184 (Direct) |
View |
| 2023-08-24 Exercise |
2023-08-25 1:57 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 63,075,184 (Direct) |
View |
| 2023-05-26 Exercise |
2023-05-30 1:14 pm |
N/A 2030-11-18 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 63,075,184 (Direct) |
View |
| 2023-05-26 Exercise |
2023-05-30 1:14 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 63,075,184 (Direct) |
View |
| 2023-05-05 Exercise |
2023-05-09 3:02 pm |
N/A 2027-03-23 |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
250,000 | $0 | 12,653,029 (Direct) |
View |
| 2023-05-05 Exercise |
2023-05-09 3:02 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
250,000 | $0.19 | 12,653,029 (Direct) |
View |
| 2023-02-22 Exercise |
2023-02-23 4:33 pm |
N/A 2030-11-18 |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $0 | 62,922,184 (Direct) |
View |
| 2023-02-22 Exercise |
2023-02-23 4:33 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
56,125 | $2.7 | 62,922,184 (Direct) |
View |
| 2022-12-20 Gift |
2022-12-22 2:31 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
50,000 | $0 | 6,089,940 (Direct) |
View |
| 2022-12-20 Exercise |
2022-12-22 2:31 pm |
N/A 2026-06-15 |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
50,000 | $0 | 6,089,940 (Direct) |
View |
| 2022-12-20 Exercise |
2022-12-22 2:31 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
50,000 | $0.19 | 6,089,940 (Direct) |
View |
| 2022-12-01 Option Award |
2022-12-05 12:34 pm |
2024-06-15 2032-12-01 |
AbCellera Biologics Inc. | ABCL | Lo Andrew Director |
47,231 | $0 | 138,556 (Direct) |
View |
| 2022-12-01 Option Award |
2022-12-05 12:33 pm |
2024-06-15 2032-12-01 |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
47,231 | $0 | 497,045 (Direct) |
View |
| 2022-12-01 Option Award |
2022-12-05 12:30 pm |
2024-06-15 2032-12-01 |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
47,231 | $0 | 627,045 (Direct) |
View |
| 2022-12-01 Option Award |
2022-12-05 12:28 pm |
N/A 2032-12-01 |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
462,535 | $0 | 3,392,689 (Direct) |
View |
| 2022-12-01 Option Award |
2022-12-05 12:22 pm |
N/A 2032-12-01 |
AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer |
346,901 | $0 | 2,658,381 (Direct) |
View |